- Home
- MFIN vs HRTX Comparison
MFIN vs HRTX Comparison
Compare MFIN & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- HRTX
- Stock Information
- Founded
- MFIN 1995
- HRTX 1983
- Country
- MFIN United States
- HRTX United States
- Employees
- MFIN N/A
- HRTX N/A
- Industry
- MFIN Finance: Consumer Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- MFIN Finance
- HRTX Health Care
- Exchange
- MFIN Nasdaq
- HRTX Nasdaq
- Market Cap
- MFIN 190.0M
- HRTX 240.3M
- IPO Year
- MFIN 1996
- HRTX 1987
- Fundamental
- Price
- MFIN $9.61
- HRTX $1.58
- Analyst Decision
- MFIN
- HRTX Strong Buy
- Analyst Count
- MFIN 0
- HRTX 3
- Target Price
- MFIN N/A
- HRTX $5.67
- AVG Volume (30 Days)
- MFIN 74.5K
- HRTX 6.1M
- Earning Date
- MFIN 02-18-2025
- HRTX 11-12-2024
- Dividend Yield
- MFIN 4.59%
- HRTX N/A
- EPS Growth
- MFIN N/A
- HRTX N/A
- EPS
- MFIN 1.69
- HRTX N/A
- Revenue
- MFIN $293,257,000.00
- HRTX $137,737,000.00
- Revenue This Year
- MFIN N/A
- HRTX $13.10
- Revenue Next Year
- MFIN $10.95
- HRTX $18.76
- P/E Ratio
- MFIN $5.66
- HRTX N/A
- Revenue Growth
- MFIN 18.48
- HRTX 12.13
- 52 Week Low
- MFIN $6.48
- HRTX $1.04
- 52 Week High
- MFIN $10.50
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- MFIN 48.59
- HRTX 48.32
- Support Level
- MFIN $9.35
- HRTX $1.46
- Resistance Level
- MFIN $10.50
- HRTX $1.88
- Average True Range (ATR)
- MFIN 0.35
- HRTX 0.12
- MACD
- MFIN -0.06
- HRTX 0.00
- Stochastic Oscillator
- MFIN 23.73
- HRTX 13.10
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.